Terminology Service < Semantic Lookup Platform

All terms in MESH

Label	Id	Description
5-(6-chloro-2,4-dioxo-1,3,4,10-tetrahydro-2H-9-oxa-1,3-diazaanthracen-10-yl)pyrimidine-2,4,6-trione	C510606
BDH2 protein, human	C510607
pragmin protein, rat	C510608
Ro43 83582	C510609
luciferase, cypridina	C485195
2-(4-biphenylyl)-5-(4-carbazole-9-yl)phenyl-1,3,4-oxadiazole	C485196
luciferase, Photinus	C485197
6,19-methanoprogesterone	C485198
Clobetasol	D002990	[A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression., This is the form in trademark preparations.]
Betamethasone	D001623	[A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)]
sorgolactone	C485199
Clofazimine	D002991	[A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619)]
Phenazines	D010619
Clofenapate	D002992	[An oral hypolipemic agent primarily used in DOGS and RATS.]
Fibric Acids	D058607	[Compounds that either share the structure of fibric acid in their molecular arrangement or are considered variants of the fibric acid structure.]
Biphenyl Compounds	D001713	[Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings.]
Clofibrate	D002994	[A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)]
Clofibric Acid	D002995	[An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.]
Clomiphene	D002996	[A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. Note that ENCLOMIPHENE and ZUCLOMIPHENE are the (E) and (Z) isomers of Clomiphene respectively.]
Stilbenes	D013267	[Organic compounds that contain 1,2-diphenylethylene as a functional group.]